SUNPHARMA - Sun Pharmaceutical Industries

Sun Pharmaceutical Industries

SUNPHARMA · Pharma > Pharmaceuticals & Drugs · Chairman: Israel Makov · MD: Dilip S Shanghvi · Listing date: Feb. 8, 1995 · Employees: 37000 · Mumbai · http://www.sunpharma.com

Stock Price vs Company Growth

0.7%

1.5%

4.2%

1.0%

5.0%

17.0%

20.1%

10y

10.1%

all

16.8%

🤔 How to analyze this graph?

Last Traded Price

₹ 1,840 0.7%

1,829

2,048

Company Overview

Sales

59,911 Cr

Growth: 10.7%

Profit after Tax

12,096 Cr

Growth: 5.4%

Large Cap

4,41,478 Cr

P/E: 36.5x

Industry P/E: 35.1x

Fundamentals

Sales (Cr)	₹ 59,911
Growth	10.7%
EBITDA	28.8%
P/S	7.4x
Dividend	1.0%
P/E	36.5x
Book Value	₹ 360
PEG Ratio	3.4x
ROE	14.7%
P/B	5.1x

Shareholding Pattern

Institutions

Life Insurance Corporation Of India

7.37 %

Icici Prudential Value Discovery Fund And Various Fund Accounts

3.68 %

Sbi-Etf Nifty 50 And Various Fund Accounts

1.94 %

Hdfc Trustee Company Limited-Hdfc Balanced Advantage Fund And Various Fund Accounts

1.37 %

Nippon Life India Trustee Ltd-A/C Nippon India Pharma Fund And Various Fund Accounts

1.24 %

Promoters

Shanghvi Finance Private Limited

40.3 %

Dilip.S.Shanghvi

9.6 %

Aditya Medisales Limited

1.67 %

Raksha S.Valia

1.2 %

Sudhir V.Valia

0.6 %

Others

Llp

2.89 %

Lakshdeep Investments & Finance (P) Ltd.

1.18 %

Iepf

0.08 %

Increase Decrease No change

Company Profile Detailed

The company is among the largest specialty generic pharmaceutical company and India's top pharmaceutical company. A vertically integrated business and a skilled team enables it to deliver high-quality products, trusted by customers and patients in many countries across the world, at affordable prices.ProductsFormulationsActive Pharmaceutical Ingredients - CramsOTCAwards 2005: Dilip Shanghvi is named Entrepreneur of the Year (Healthcare and Life Science) Ernst & Young.

Belongs to (64 Indices) view more

Investors (338)

subson

maninder...

nitesh

Followers (136)

bharath....

kiran198...

anil